Pregabalin vs. Roxicet: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Pregabalin and Roxicet. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 473,224 people who take Pregabalin and Roxicet, and is updated regularly.
What is Pregabalin?
Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,071 Pregabalin users. Check the latest studies of Pregabalin.
What is Roxicet?
Roxicet has active ingredients of acetaminophen; oxycodone hydrochloride. It is often used in pain. eHealthMe is studying from 2,254 Roxicet users. Check the latest studies of Roxicet.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
473,224 people who take Pregabalin and Roxicet are studied.
Drugs being compared in this study:
- Pregabalin (pregabalin)
- Roxicet (acetaminophen; oxycodone hydrochloride)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Pregabalin:
- not at all: 6.0 %
- somewhat: 25.72 %
- moderate: 33.65 %
- high: 24.88 %
- very high: 9.74 %
Roxicet:
- not at all: 1.99 %
- somewhat: 19.58 %
- moderate: 40.51 %
- high: 29.47 %
- very high: 8.46 %
Want to compare Pregabalin with Roxicet?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
- de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
- Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
Related studies
Alternative drugs to, pros and cons of:
- Pregabalin (73,061 reports)
- Roxicet (2,148 reports)
Browse all side effects of Pregabalin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Roxicet:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on pregabalin and acetaminophen; oxycodone hydrochloride (the active ingredients of Pregabalin and Roxicet, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Canagliflozin cause Crohn'S Disease? - 4 seconds ago
- Blood Glucose Increased and Anorectal Abscess - 7 seconds ago
- Could Doxorubicin Hydrochloride cause Pseudomonas Infection? - 11 seconds ago
- Could Gabapentin cause Long Qt Syndrome? - 21 seconds ago
- Could Uptravi cause Eczema? - 22 seconds ago
- Could Uptravi cause Dermatitis - Atopic? - 23 seconds ago
- Drug interactions of Flonase and Pepcid - 23 seconds ago
- Could Invokana cause Hearing Loss? - 25 seconds ago
- Could Progesterone cause Hypospadias? - 33 seconds ago
- Could Nexium cause Osteoporosis? - 35 seconds ago